Short Interest in Burning Rock Biotech Limited (NASDAQ:BNR) Declines By 10.3%

Burning Rock Biotech Limited (NASDAQ:BNR) was the recipient of a large drop in short interest in November. As of November 30th, there was short interest totalling 72,300 shares, a drop of 10.3% from the November 15th total of 80,600 shares. Based on an average daily trading volume, of 33,600 shares, the days-to-cover ratio is currently 2.2 days. Currently, 0.9% of the shares of the stock are sold short.

Institutional Trading of Burning Rock Biotech

An institutional investor recently bought a new position in Burning Rock Biotech stock. SkyView Investment Advisors LLC purchased a new position in Burning Rock Biotech Limited (NASDAQ:BNR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 10,000 shares of the company’s stock, valued at approximately $64,000. SkyView Investment Advisors LLC owned about 0.10% of Burning Rock Biotech as of its most recent SEC filing. Hedge funds and other institutional investors own 30.03% of the company’s stock.

Burning Rock Biotech Trading Up 1.5 %

Shares of Burning Rock Biotech stock traded up $0.10 on Monday, hitting $6.83. 2,959 shares of the company traded hands, compared to its average volume of 13,882. The firm’s 50-day simple moving average is $4.28 and its 200 day simple moving average is $5.35. The company has a market cap of $69.97 million, a P/E ratio of -2.24 and a beta of 0.60. Burning Rock Biotech has a 12-month low of $2.62 and a 12-month high of $9.99.

Burning Rock Biotech Company Profile

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples.